MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races

Core Insights - Abbott and MotoAmerica have partnered to implement Abbott's i-STAT TBI test for concussion assessment at all MotoAmerica races, marking a significant advancement in sports medicine [1][3] Company Overview - Abbott is a global healthcare leader with a diverse portfolio in diagnostics, medical devices, nutritionals, and branded generic medicines, serving over 160 countries with 114,000 employees [11] - The i-STAT TBI test cartridge was developed with support from the U.S. Army Medical Research and Development Command and the TRACK-TBI research team, highlighting collaboration with military and research institutions [8][12] Product Details - The i-STAT TBI test cartridge evaluates patients aged 18 and older for suspected mild traumatic brain injury, providing results in 15 minutes and can be used up to 24 hours post-injury [2][7] - The test measures two brain-specific biomarkers, UCH-L1 and GFAP, to objectively assess the need for a CT scan, potentially avoiding unnecessary imaging [6][9] Industry Impact - The introduction of the i-STAT TBI test in MotoAmerica enhances rider safety by allowing for immediate on-site assessment of concussions, which is crucial in high-speed sports [3][5] - The CDC reports that traumatic brain injuries from accidents or sports lead to 2.5 million emergency department visits annually, underscoring the importance of rapid assessment tools like the i-STAT TBI test [5]